US-based Seno Medical Instruments has announced new statistical analysis of outcomes from a feasibility study of its investigational Imagio breast imaging device. The analysis of data from the feasibility study, presented at the San ...
Metabolism was lost in the shadows of cancer research for decades but has recently been reclaiming some of the spotlight. Now, Mina Bissell, Distinguished Scientist with Berkeley Lab's Life Sciences Division and a leading authority on ...
Ventana Medical Systems (Ventana), a member of the Roche Group, has announced that its Ventana HER2/neu (4B5) rabbit monoclonal primary antibody assay is now a companion diagnostic for detecting HER2 protein expression for patients who, in ...
Tags: Ventana, Medical Systems
NanoString Technologies has announced new results from a combined analysis of the Austrian Breast & Colorectal Cancer Study Group 8 (ABCSG-8) and Trans-Arimidex, Tamoxifen, Alone or in Combination (TransATAC) studies. These results, which ...
Worldwide, 14 million people developed cancer last year up from 12.7 million cases in 2008, the International Agency for Research on Cancer in Switzerland said. David Forman, bead of the IARC Section of Cancer Information, the group that ...
Tags: Breast Cancer, women health
One year of exercise can ensure steady maintenance of bone density to help prevent fractures in older breast cancer survivors, U.S. researchers say. Lead author Jessica Dobek and Kerri Winters-Stone, both of the Oregon Health and Science ...
Tags: exercise, health, cancer treatment
Novian Health, the developer of Novilase breast therapy, has announced the issuance of a new US patent covering the interstitial laser therapy in combination with interstitial brachytherapy treatment. Novian Health has developed the ...
Tags: Novian Health, Breast Cancer
Ventana Medical Systems, a member of the Roche Group, has obtained the US Food and Drug Administration’s (FDA) 510(k) approval for its Companion Algorithm ER (SP1) image analysis algorithm used with the Ventana iScan Coreo scanner ...
Tags: Breast Cancer, Analysis Algorithm
More than a week after the FDA told 23andMe to stop marketing its Personal Genomic Service tests, the Mountain View, CA–based company says it is complying. "23andMe halted all marketing last week in accordance with the FDA’s ...
A guitar owned and signed by Queen guitarist Brian May will be up for grabs at the UK Lingerie Awards 2013 in association with Fashion Forms, with 100% of the sale price being donated to charity Breast Cancer Campaign through Rock & Ribbon, ...
US-basedd VuCOMP has announced that M-Vu CAD, the first mammography CAD product clinically proven in a pivotal reader study, is available as a companion technology for the Siemens MAMMOMAT Inspiration PRIME Edition, MAMMOMAT Inspiration, ...
Tags: Healthcare, Health, Medicine
Shannon's winning "Live Beautifully" Pinterest board. In support of Susan G. Komen, Mohawk commemorated National Breast Cancer Awareness Month with two consumer-based social media contests. The contests were designed to engage consumers ...
Tags: Mohawk Break Cancer, awareness, Month Contest, winner, announced
Posted in Testing Services by Chris Newmarker on November 25, 2013 The FDA is telling 23andMe to stop marketing its Personal Genomic Service tests. The FDA’s move is but another sign that the regulator is increasingly concerned ...
Tags: 23andMe, DNA, Hit, FDA, warning letter
The U.S. Food and Drug Administration halted the selling of the 23andMe Saliva Collection Kit and Personal Genome Service -- a home DNA test. In a letter posted on its website, the FDA alleged 23andMe was being sold without clearance or ...
Myriad Genetics, a molecular diagnostic company, and biotechnology firm BioMarin Pharmaceutical have signed a research collaboration agreement for identifying tumor types that may be sensitive to BioMarin's investigational product ...
Tags: Myriad Genetics, Biomarin